| CAR-T cells with phytohemagglutinin (PHA) provide anti-cancer capacity with better proliferation, rejuvenated effector memory, and reduced exhausted t cell frequencies G Gulden, B Sert, T Teymur, Y Ay, NN Tiryaki, AK Mishra, E Ovali, ... Vaccines 11 (2), 313, 2023 | 4 | 2023 |
| Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy (SMA) Disease Can Increase In Vitro SMN Expression SP Odabas, E Bal, G Yelgen, AS Metin, E Karakaya, G Gulden, B Sert, ... bioRxiv, 2022.03. 21.484406, 2022 | 1 | 2022 |
| Enhancing CAR-T cells: unleashing lasting impact potential with phytohemagglutinin activation in in vivo leukemia model B Sert, G Gulden, T Teymur, Y Ay, RD Turan, OM Unaldi, E Guzenge, ... Cancer Gene Therapy 31 (3), 387-396, 2024 | | 2024 |
| Phytohemagglutinin-Activated CAR-T Cells: Prolonged Persistence and Enhanced Anti-Tumor Response in CD19-Specific Acute Lymphoblastic Leukemia B Sert, G Gulden, T Teymur, Y Ay, RD Turan, OM Unaldi, E Guzenge, ... bioRxiv, 2023.07. 15.547808, 2023 | | 2023 |
| Autonomous Remotely Controlled Closed System Transgenic Cell Technologies Robot: CRISPR. BOT (preprint) F Erkek, G Gulden, B Sert, MC Yilmaz, SP Odabas, E Bal, G Yelgen, ... | | 2022 |
